MannKind Corp. (MNKD)

[TREND1]

najak
Comments (1477) |+ Follow |Send Message

Those hoping for a buyout will most likely be disappointed. No company would be dumb enough to buy MNKD pre-BK. Think about it -- post-BK, they are absolved of their debts and owe nothing to share holders. To buy MNKD pre-BK would cost $300M+, for a product that sells 300 prescriptions a week. Who would be dumb enough?
Better to file BK, restructure the debts, let the equity drop to zero, and sell the rest to the highest bidder. In this mode, a company could buy Afrezza for < $100MB, a fraction of the cost to buying it pre-BK.
Stock holders become their LAST concern. Debt holders come before common stock, and so you can expect near nothing as a result.
Because that could happen now at any time, I don't want to be caught sitting on this toilet when the music stops, they announce BK, and the stock drops to a dime.
Think about it now -- why spend another $30M over the next 3 months, when they could file BK now, and ensure that the debts mostly all get paid, but leaving equity holders with nothing.
I give them a 50/50 chance of going this route before end of summer, and IMO, it could happen any day now, given that it's pretty clear now that their magic-new-sales-force is not the answer.
It's a shame. I once enjoyed trading this stock, but no longer see reason enough for optimism to justify even a quick swing trade.